CP2D

Intended use

Intended for use only with automated red cell apheresis devices
to collect red blood cells and plasma (FFP and PF24).

Storage and handling

Store at room temperature (25 °C/77 °F). Avoid excessive heat.
Protect from freezing.

Warnings and precautions

Warnings

Not for direct intravenous infusion.

Single-use container – discard unused portion. (do not reuse)

Do not use unless the solution is clear and no leaks are detected.

Precautions

Use only with automated red-cell apheresis devices and follow the Operator’s Manual.

Refer to the package insert for complete instructions.

Storage/handling: Store at 25 °C/77 °F, avoid excessive heat, protect from freezing.

Pouch is a moisture barrier; handle to maintain package integrity.

Description

ANTICOAGULANT CITRATE PHOSPHATE DOUBLE

DEXTROSE SOLUTION (CP2D), 250 mL

0455A-00

Statement of identity

ANTICOAGULANT CITRATE PHOSPHATE DOUBLE
DEXTROSE SOLUTION (CP2D), 250 mL

0455A-00

Package label

Manufacturer information: GVS TM Inc.
1630 W Industrial Park St
Covina, CA 91722, USA

ANTICOAGULANT CITRATE PHOSPHATE DOUBLE
DEXTROSE SOLUTION (CP2D), 250 mL

Intended for use only with automated red cell apheresis devices
to collect red blood cells and plasma (FFP and PF24). See the
appropriate Operator’s Manual for additional information and
complete usage instructions.
Each 100 mL contains:
Citric Acid (Monohydrate), USP 0.327 g
Sodium Citrate (Dihydrate), USP 2.630 g
Monobasic Sodium Phosphate (Monohydrate), USP 0.222 g
Dextrose (Anhydrous), USP 4.640 g
CAUTION: Refer to package insert. Not for direct intravenous
infusion. The pouch is a moisture barrier.
Do not use unless solution is clear and no leaks detected.
Single use container. Discard unused portion.
Sterile, nonpyrogenic fluid path. Sterilized by steam. Rx Only.
Store at room temperature (25 °C/77 °F). Avoid excessive heat.
Protect from freezing.

REF: 0455A-00

lot and expiry date

126616-00 REV.0 - template number